SCHEMBL26324940

SCHEMBL26324940

Cc1ccc(N(c2ccccc2)C(C(=O)OC(C)C)C(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.39
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 1/20 0.36
PTGIR P43119 1/20 0.36
PTGDR Q13258 1/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324999 0.94 ALOX5 (0.37) ALDH1A1NPSR1TDP1TSHRKMT2A
SCHEMBL26324800 0.92 TSHR (0.42) ALDH1A1NPSR1TDP1TSHRPDCD1
SCHEMBL26324953 0.89 HSD17B1 (0.40) ALDH1A1NPSR1KMT2AHTTNPC1
SCHEMBL26324955 0.88 PDCD1 (0.50) TSHRPDCD1CD274NPC1MAPT
SCHEMBL26325014 0.87 PDCD1 (0.51) TSHRPDCD1CD274NPC1MAPT
SCHEMBL26324957 0.86 PTGS1 (0.41) ALDH1A1SMN1; SMN2MMP2MMP9MMP8
SCHEMBL25439798 0.85 TRPM8 (0.40) TRPM8ALDH1A1NPSR1TDP1TSHR
SCHEMBL26324996 0.85 ALDH1A1 (0.37) ALDH1A1NPSR1TSHRKMT2ASMN1; SMN2
SCHEMBL26324995 0.84 PTGS1 (0.42) ALDH1A1SMN1; SMN2MMP2MMP9MMP8
SCHEMBL26324971 0.81 TP53 (0.39) TRPM8ALDH1A1NPSR1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TRPM8 4135/4885ALDH1A1 1805/4885NPSR1 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.